InvestorsHub Logo
Followers 33
Posts 2049
Boards Moderated 0
Alias Born 11/06/2011

Re: learningcurve2020 post# 32633

Thursday, 12/29/2022 11:24:09 AM

Thursday, December 29, 2022 11:24:09 AM

Post# of 34625
There might be some value in their manufacturing facility but I wouldn't expect it to be much. Wilson Wolf did give them $8M, with the potential for an extra $1M, "in exchange for services relating to Marker’s expertise in the manufacture of cell therapies." That's almost half the current market cap.

Either way, they need to get their trials running full tilt so they can get data. Its been four years and they have data on like 13 patients. That's unacceptable. What's worse is they backed themselves into this corner where they will be in dire need of cash because they chose to keep tweaking their manufacturing process while putting their only trial on hold. They took what should have been a great financing deal and did it with a garbage company in LPC. Also, looks like they won't report the data that they were supposed to, again, and until they do the price will continue to stagnate or decline.

We pretty much know most of the news that is possible between now and the inevitable RS and I don't believe it will be enough to do much for the share price. If the next data set was going to blow anyone away they should have released it already. We should know by the next data release how hard this trial delay screwed the shareholders.

Sorry for the rant. My patience is really being tested right now, lol.

My DD is not a substitute for your DD

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News